Tag:
Latest Headlines
Federal regulators' decision to revise how star ratings are deducted from sanctioned Medicare Advantage plans will preserve millions of dollars in quality bonuses for Cigna--but some consumer advocates say the shift undermines health plans' accountability, Kaiser Health News reports.
Private insurers that offer Medicare Advantage plans are increasingly investing in quality initiatives that provide a boost to the plan's star rating tied to millions of dollars in government incentives, according to an article by Kaiser Health News, published by USA Today.
The Pennsylvania physician community lashed out against a recent decision by one of the state's major insurance carriers to cut payments by 4.5 percent, claiming the cuts are placing an unfair burden on providers, which could negatively impact patient care in the long run.
Providers who specialize in addiction services are scrambling to rehabilitate the industry's image following high profile fraud cases that have caught the attention of federal regulators and private insurers, according to the Palm Beach Post.
As part of a broader effort to stem losses from Affordable Care Act plans, insurer Highmark, Inc. will cut physician reimbursement rates for those plans by 4.5 percent starting in April.
Though some health insurance giants have recently expressed skepticism about the sustainability of the Affordable Care Act marketplace, the Hartford Courant reports that a top Cigna executive has taken a more optimistic view.
The recent performance-based deal that Novartis cut with two insurance giants could signal the beginnings of a new approach to drug pricing, according to a Bloomberg editorial.
If the "big five" U.S. health insurers' fourth-quarter earnings reports made one fact clear, it's that the profitability of their Affordable Care Act exchange products continues to be an issue.
Health insurer Cigna has teamed up with Swiss drugmaker Novartis AG to set the price for a new heart medication based on performance, Reuters reports.
Cigna reported Thursday that its fourth-quarter adjusted income from operations rose to $486 million, or $1.87 per share, up from $475 million ($1.80 per share) at the same time in 2014.
Press Releases
- AHIMA Launches Petition for National Voluntary Patient Safety Identifier
- HHS announces major commitments from healthcare industry to make electronic health records work better for patients and providers
- Statement by Theranos on CMS Audit Results
- MISSING PIECES: MAJOR HEALTH DATABASE HAS DEEP FLAWS
- Majority of Americans Don't Use Digital Technology to Access their Doctors
- More Press Releases
Sponsored Links